# Enliven Therapeutics (ELVN) - Q1 2025 earnings

Reported May 14, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.57 | $-0.51 |

Earnings filing reader: [8-K 0000950170-25-071387](https://www.opencapital.sh/filings/0000950170-25-071387)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0000950170-25-071387.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1672619/0000950170-25-071387-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1672619/0000950170-25-071412-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/elvn/earnings/q1-2025